bioMérieux Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	380.5	449.8	352.4	552.6	803.5	389.2
Cash & Short-Term Investments	380.5	449.8	352.4	552.6	803.5	389.2
Cash Growth	39.79%	27.64%	-36.23%	-31.23%	106.45%	41.53%
Accounts Receivable	688.4	792.3	728.6	740.1	590.6	597.9
Other Receivables	234.1	146.4	131.7	116.6	118.3	84.2
Receivables	922.5	938.7	860.3	856.7	708.9	682.1
Inventory	973.9	1,037	908.5	737.2	620	541.9
Prepaid Expenses	-	33	38.6	31.4	23.9	20.7
Other Current Assets	-	42.3	45.4	38.8	36.2	27.6
Total Current Assets	2,277	2,501	2,205	2,217	2,193	1,662
Property, Plant & Equipment	1,593	1,696	1,506	1,370	1,225	1,069
Long-Term Investments	162.7	180.2	206	71.2	34.5	39.9
Goodwill	727.6	730.4	698.8	812.5	669.5	629.4
Other Intangible Assets	411.4	492	528.6	625	411.5	430.7
Long-Term Accounts Receivable	8.5	9.1	7.7	12.9	12.6	14.3
Long-Term Deferred Tax Assets	186.7	145.9	92.7	58.7	32	72.6
Other Long-Term Assets	-0.1	0.1	-	-0.1	0.1	0.1
Total Assets	5,366	5,770	5,259	5,187	4,605	3,928
Accounts Payable	228.9	272.4	265.1	269.4	239.5	207.1
Accrued Expenses	-	451.6	378.7	372.7	318	327.4
Short-Term Debt	33.5	17.7	29	53.9	26.3	52.9
Current Portion of Long-Term Debt	109.6	94.4	107	106.9	48.6	51.6
Current Portion of Leases	29	29.4	27.4	26.2	24.8	24.4
Current Income Taxes Payable	27.6	35.4	52.8	49	67.4	44.3
Current Unearned Revenue	-	87.4	80.1	88.5	84	68.7
Other Current Liabilities	576.3	146.6	147.2	164.5	147.2	147.4
Total Current Liabilities	1,005	1,135	1,087	1,131	955.8	923.8
Long-Term Debt	212.9	206.6	234.2	224.7	265.2	249.2
Long-Term Leases	121.4	142.6	121.2	93.7	97.6	103.2
Long-Term Deferred Tax Liabilities	34.9	25.7	11.1	53	60.3	105.8
Other Long-Term Liabilities	54.3	49.2	53.2	41.2	62.5	64.4
Total Liabilities	1,428	1,559	1,507	1,544	1,441	1,446
Common Stock	12	12	12	12	12	12
Additional Paid-In Capital	4,013	3,667	3,420	3,062	2,532	63.7
Retained Earnings	161	432.2	357.6	452.4	601.1	404.4
Treasury Stock	-30.2	-42.9	-19.1	-36	-10.3	-23.1
Comprehensive Income & Other	-221.6	136.7	-18.5	113.6	-22.7	1,974
Total Common Equity	3,934	4,205	3,752	3,604	3,112	2,431
Minority Interest	4	6.1	-	38.7	51.4	50.2
Shareholders' Equity	3,938	4,211	3,752	3,643	3,164	2,481
Total Liabilities & Equity	5,366	5,770	5,259	5,187	4,605	3,928
Total Debt	506.4	490.7	518.8	505.4	462.5	481.3
Net Cash (Debt)	-125.9	-40.9	-166.4	47.2	341	-92.1
Net Cash Growth	-	-	-	-86.16%	-	-
Net Cash Per Share	-1.06	-0.34	-1.40	0.40	2.87	-0.78
Filing Date Shares Outstanding	118.07	117.93	118.16	117.92	118.25	118.14
Total Common Shares Outstanding	118.07	117.92	118.15	118	118.27	118.15
Working Capital	1,272	1,366	1,118	1,086	1,237	737.7
Book Value Per Share	33.32	35.66	31.76	30.54	26.32	20.58
Tangible Book Value	2,795	2,983	2,525	2,167	2,031	1,371
Tangible Book Value Per Share	23.67	25.29	21.37	18.36	17.17	11.61
Land	60.3	63.6	58.5	56.5	54.5	51.3
Buildings	920.8	954.2	845.5	823.5	742.7	645.9
Machinery	806.4	808	785.3	682.2	626.4	536.2
Construction In Progress	311.2	355.4	249.6	227.1	157.1	130

Source: S&P Global Market Intelligence. Standard template. Financial Sources.